Speakers

Final Discount Expires Friday!

Day
Hour
Minute
Second

Navigate the 2022 Speakers Using the Buttons Below:

Workshop Day Speakers

Adrian Bot

Chief Scientific Officer & Executive Vice President, Research & Development

Capstan Therapeutics

Angela Justice

Chief People Officer

TCR2

Arnaud Deladeriere

Director of Process Development

Triumvira Immunologics

Birgit Schultes

Senior Vice President, Head of Cell Therapies

Intellia Therapeutics

Brad Hartman

Chief People Officer

Be Biopharma

Chris Baldwin

Senior Director, Cell & Gene Therapy Supply Chain

GlaxoSmithKline

Colleen Delaney

Founder & Chief Scientific Officer, Executive Vice President of Research & Development

Deverra Therapeutics

Damien Fink

Director of Analytical Development

Century Therapeutics

Damien Hallet

Vice President, Head of CMC

Affini-T Therapeutics

Daniel Abate-Daga

Associate Professor

H. Lee Moffitt Cancer Center & Research Institute & University of South Florida

Elena Peletskaya

Senior Scientific Director, GDE Portfolio Technical Strategy

Bristol Myers Squibb

Ellie Corigliano

Head of CDx Cell & Gene Therapy, Global Clinical Development

GSK

Haig Aghajanian

Vice President of Research

Capstan Therapeutics

Helen Tayton-Martin

Chief Business Officer

Adaptimmune

Joseph Gold

Vice President of Technical Operations & Manufacturing

Catamaran

Luis Borges

Chief Scientific Officer

Century Therapeutics

Madan Jagasia

Senior Vice President Medical Affairs

Iovance Biotherapeutics

Michael Leek

Chief Executive Officer

Executive Chairman and Founder

Neil Sheppard

Director, T Cell Engineering Lab

University of Pennsylvania, Center for Cellular Immunotherapies

Nicole Hilgraf

Director, CMC Regulatory Affairs

Allogene

Oliver Eitelwein

Partner, Health & Life Sciences

Oliver Wyman

Qi Cai

Director of Biology

Kite Pharma

Ranjeeva Ranasinghe

Product Director, Cell & Gene Therapy

GlaxoSmithKline

Reagan Jarvis

Co-Founder & Chief Executive Officer

Anocca

Sven Kili

Chief Executive Officer

Antion Biosciences

Vipin Suri

Chief Scientific Officer

Catamaran Bio

Zhimei Du

Vice President of Process Development

Atara

Bootcamp Speakers

Adrian Bot

Chief Scientific Officer & Executive Vice President, Research & Development

Capstan Therapeutics

Angela Justice

Chief People Officer

TCR2

Brad Hartman

Chief People Officer

Be Biopharma

Daniel Powell

Associate Professor of Pathology & Lab Medicine

University of Pennsylvania

Eric von Hofe

Senior Advisor

AffyImmune Therapeutics

Helen Tayton-Martin

Chief Business Officer

Adaptimmune

Jens Hasskarl

Chief Medical Officer

Tigen Pharma

Luis Borges

Chief Scientific Officer

Century Therapeutics

Miloš Miljković

Chief Medical Officer

Cartesian Therapeutics

Samik Basu

Chief Scientific Officer

Cabaletta Bio

Stanley Frankel

Chief Medical Officer

Cytovia

Tony Ho

Industry Expert, Self Employed

Previously CRISPR Therapeutics

Focus Day Speakers

Aaron Cooper

Senior Director of Synthetic Biology

Arsenal Bio

Amy Jensen-Smith

Senior Director, Head of Discovery Research

SOTIO Biotech

Blythe Sather

Vice President, Head of Research

Tune Therapeutics

Christopher Bond

Vice President Preclinical & Translational Sciences

Notch Therapeutics

Daniel Corey

Chief Scientific Officer

CERo Bio

Erika von Euw

Vice President, Discovery & Translational Research

Devarra Therapeutics

Gary Lee

Chief Scientific Officer

Lyell Pharma

Gregory Fiore

CEO

Exacis Biotherapeutics

Hiroshi Shiku

Professor

Mie University Graduate School of Medicine

Lan Cao

Vice President, Head of Cell Therapy Innovation, Oncology Cell Therapy & Therapeutic Area Unit

Takeda

Lawrence Lamb

Chief Scientific Officer

IN8Bio

Marc Davies

Vice President, CAR Engineering

LEUCID Bio

Marc van Dijk

Chief Scientific Officer

MiNK Therapeutics

Michael O’Dwyer

Chief Scientific Officer

ONK Therapeutics

Michelle Le

Scientist

Beam Therapeutics

Miloš Miljković

Chief Medical Officer

Cartesian Therapeutics

Neil Sheppard

Director, T Cell Engineering Lab

University of Pennsylvania, Center for Cellular Immunotherapies

Parameswaran Hari

Senior Vice President Clinical Sciences

Iovance Biotherapeutics

Sareina Wu

Founder, Chief Scientific Officer

Genome Frontier

Stanley Frankel

Chief Medical Officer

Cytovia

Steven Katz

Chief Medical Officer

TriSalus Life Sciences

Tony Ho

Industry Expert, Self Employed

Previously CRISPR Therapeutics

Yu-Waye Chu

Chief Medical Officer

Fate Therapeutics

Tech Slam Speakers

Jonathan Wofford

Senior Director of Architecture

WellSky

Plenary Speakers

Adrian Bot

Chief Scientific Officer & Executive Vice President, Research & Development

Capstan Therapeutics

Arthur Stril

Chief Business Officer

Cellectis

Bob Valamehr

Chief Research & Development Officer

Fate Therapeutics

Christina Coughlin

Chief Executive Officer

Cytoimmune

Dominic Clarke

Chief Technical Officer, Cell & Gene Therapy

Discovery Life Sciences

Gary Lee

Chief Scientific Officer

Lyell Pharma

Ivie Aifuwa

Associate Director, Process Technology Development

Bristol Myers Squibb

Joe Garrity

Head of Commercial Development Cell & Gene Therapies

Lonza

Julia Coronella

Vice President, Immuno-Oncology

Poseida Therapeutics

Lynelle Hoch

Senior Vice President

Bristol Myers Squibb

Nicholas Boyle

Co-Founder, Chief Executive Officer

Abintus Bio

Pascal Touchon

President, Chief Executive Officer

Atara Biotherapeutics

Tamara Laskowski

Head of Clinical Development Personalized Medicine

Lonza

Travis Young

Vice President Biologics

Calibr at Scripps Research

Warner Biddle

Senior Vice President & Global Head of Commercial

Kite Pharma

Xavier de Mollerat du Jeu

Senior Director of Research & Development

Thermo Fisher Scientific

Discovery Track Speakers

Aaron Sato

Chief Scientific Officer

Twist Bioscience

Bakul Gupta

Chief Executive Officer

ImmTune Therapies

Branden Smeester

R&D Scientist

Horizon Discovery

Dan MacLeod

Vice President, Discovery

ImmunoScape

Daniel Powell

Associate Professor of Pathology & Lab Medicine

University of Pennsylvania

Daniel Shelly

Vice President Business Development & Alliances

Prescient Therapeutics

David Fontana

Chief Business & Strategy Officer

Umoja Biopharma

Ely Porter

Co-founder, Chief Technology Officer

Rootpath

Erik Yusko

Senior Director, Drug Discovery

Adaptive Biotechnologies

Geofrey Hodge

Chief Executive Officer

SOTIO Biotech

Jacob Becraft

Co-Founder, Chief Executive Officer

Strand Therapeutics

James Chung

Chief Medical Officer

Kyverna Therapeutics

Knut Niss

Chief Technology Officer

Mustang Bio

Leah Sibener

Co-Founder, Vice President of Therapeutic Discovery

3T Biosciences

Luke Pase

Chief Technology Officer

Anocca

Sam Cobb

Chief Executive Officer

Currus Biologics

Sylvain Simon

Postdoctoral Fellow

Fred Hutchinson Cancer Research Center

Will Singleterry

Commercial Director, Immuno-Oncology

LUMICKS

Youngzee Song

R&D Manager

Thermo Fisher

Translation Track Speakers

Archana Thakur

Associate Professor of Medicine, Director of Human Cellular Therapeutics cGMP Core

University of Virginia, School of Medicine

Brian Champion

Chief Scientific Officer

PsiOxus Therapeutics

Cheng Liu

Founder, Chief Executive Officer

Eureka Therapeutics

Elie Haddad

Professor, Department of Pediatrics

University of Montreal

Francesco Galimi

Chief Medical Officer

Adicet Bio

Indu Ramachandran

Head of Translational Development

Century Therapeutics

James Keck

Senior Director of Innovation & Product Development

The Jackson Laboratory

Jennifer Chow

Chief Executive Officer, Managing Director

Chimeric Therapeutics

Jim Johnston

Chief Scientific Officer

Immpact Bio

John Rossi

Senior Vice President, Head of Translational Medicine

CERo Therapeutics

Kathryn Newhall

Vice President, Head of Translational Research

Cellectis

Kumar Karyampudi

Director, Cell Therapies Facility

Moffitt Cancer Center

Lior Goldberg

Pediatric Oncologist, Physician-Scientist

City of Hope Comprehensive Cancer Center

Mark Throsby

Chief Operating Officer, Chief Scientific Officer

Gadeta

Paul Rennert

Acting Chief Executive Officer, President, Chief Scientific Officer

Aleta Biotherapeutics

Rebecca Nugent

Vice President, Platform Research

Synthego

Rizwan Romee

Associate Professor of Medicine

Dana-Farber Cancer Institute, Harvard Medical School

Scott Kitchen

Professor, Director

University of California Los Angeles

Vita Golubovskaya

Senior Director, Research & Development, Business Development

ProMab Biotechnologies

Clinical Management Track Speakers

Christopher Heery

Chief Medical Officer

Arcellx

Eric Von Hofe

Senior Advisor

AffyImmune

Eugene Kennedy

Chief Medical Officer

Innovative Cellular Therapeutics

Gaurav Nurala

Professor Pediatric Oncology & Health Sciences, Department of Medical Oncology

Tata Memorial Center, Homi Bhabha National Institute

Harb Wael

Vice President, Medical Affairs

Syneos Health

Helen Tayton-Martin

Chief Business Officer

Adaptimmune

Hong Ma

Senior Vice President - Clinical Development

CARsgen Therapeutics

Hy Levitsky

President, Research & Development

Century Therapeutics

Jim Wise

Vice President, Head of Center for Immuno-Oncology, Cellular & Gene Therapy

ICON Global Operations

Michael Singer

Chief Scientific Officer

Cartesian Therapeutics

Paul Rennert

Acting Chief Executive Officer, President, Chief Scientific Officer

Aleta Biotherapeutics

Rebecca Lim

Vice President, Scientific Affairs

Prescient Therapeutics

Robert Mabry

Chief Scientific Officer

Orna Therapeutics

Sophia Shamsi

Lead Analyst

Beacon Targeted Therapies

Taylor Jensen

Vice President, Head of Oncology Science

Labcorp

Teng Peng

Senior Technique Application Manager

ACRO Biosystems

Early Phase Development Track Speakers

Anne Kerber

Senior Vice President

Bristol Myers Squibb

Bertie MacArthur

Sales Manager

Beacon Targeted Therapies

Bradley Glover

Chief Technology Officer

Cellularity

Elisa Kieback

Co-Founder, Chief Technology Officer

T-Knife Therapeutics

Ellie Kamaloo 

Senior Scientist, Manager

Beam Therapeutics

Erin Karski

Executive Director

Allogene Therapeutics

Gemma Moiset

Group Leader

Charles River Laboratories

Kate Rochlin

Chief Operating Officer

IN8bio

Luis Borges

Chief Scientific Officer

Century Therapeutics

Michael Mehler

Director, Global Site Operations

Immatics

Michael Phelan

Application Scientist

Integral Molecular

Pascal Touchon

President, Chief Executive Officer

Atara Biotherapeutics

Robert Margolin

Vice President of Commercial, BioProducts Business

Akron Bio

Robert Richards

Administrative Director of Cell Therapy & Transplant 

University of Pennsylvania

Syed Rizvi

Chief Medical Officer

Caribou Biosciences

Tristan Holland

Laboratory Head, TCR Discovery

Medigene

William Kelce

Executive Director & Early Development Strategy

OncoBay Clinical

Manufacturing Track Speakers

Albeena Nisar

Scientific Officer, CAR-T Cell Therapy Centre & cGMP Cell Therapy Centre

Tata Memorial Center, Homi Bhabha National Institute

Arvind Natarajan

Senior Vice President, Process & Analytical Process Development

Iovance

Birgit Schultes

Senior Vice President, Head of Cell Therapies

Intellia Therapeutics

Bradley Glover

Chief Technology Officer

Cellularity

Branden Smeester

R&D Scientist

Horizon Discovery

Bruce Levine

Barbara & Edward Netter Professor in Cancer Gene Therapy

University of Pennsylvania

Charles Mooney

Vice President Bio-Development Oklahoma Blood Institute & Member

Blood Centers of America & BCA CT Network

Cory Bentley

Co-Founder, Senior Vice President

Abintus Bio

Emily Titus

Vice President

Notch Therapeutics

Evan Zynda

Senior Scientist

Thermo Fisher Scientific

Fabian Gerlinghaus

Co-Founder & Chief Executive Officer

Cellares

Hanna Lesch

Chief Technology Officer

Exothera

Jenna Balestrini

Head of Strategy & Business Development for Bioprocessing

Draper

John Lee

Vice President of Cell Therapy

Center for Breakthrough Medicine

Justin Skoble

Vice President, Technical Operations

Caribou Biosciences

Katsuhiko Nakashima

Associate Director, MSAT

Minaris

Martin Giedlin

Senior Vice President

PACT Pharma Inc.

Michael Birnbaum

Associate Professor, Department of Biological Engineering

Massachusetts Institute of Technology

Peter Olagunju

Chief Technology Officer

TCR2 Therapeutics

Sareina Wu

Founder, Chief Scientific Officer

Genome Frontier

Sid Kerkar

Vice President, Head of Research & Development

Exuma Biotechnology

Wassim Basheer

Senior Product Manager

Charles River Laboratories

CMC/Analytics Track Speakers

Aish Sathyanarayan

Senior Scientist, Process Analytics

Poseida Therapeutics

Anthony Colenburg

Director of Quality

Adicet Bio

Antoine Suteau

Senior Quality Assurance Manager, Cell & Gene Therapy

Novartis

Giuliana Vallanti

Head, Development & Global Cell & Gene Therapy R&D

AGC Biologics

Isabelle Riviere

Director, Cell Therapy & Cell Engineering Laboratory

Memorial Sloan Kettering Cancer Center

Jason Foster

Chief Executive Officer

Oribiotech

Julia Gilden

Senior Scientist

Promega

Karen Walker

Chief Technology Officer

Kyverna Therapeutics

Kumar Karyampudi

Director, Cell Therapies Facility

Moffitt Cancer Center

Lili Wang

Senior Research Scientist

National Institute of Standards & Technology

Michael Lehmicke

Vice President, Science & Industry Affairs

The Alliance for Regenerative Medicine

Michael Marit

Associate Director, MSAT

Triumvira Immunologics

Pete Cotter

Associate Director

Vor Biopharma

Raedun Clarke

Senior Director, Process Development

Fate Therapeutics

Wenzhong Guo

Chief Technology Officer, Cell Therapy

Sorrento Therapeutics

Zankar Desai

Assistant Technical Director - Cell Therapy Testing Lab

Dana-Farber Cancer Institute

Logistics Track Speakers

Aaron Vernon

Vice President, Manufacturing

TCR2 Therapeutics

Andrea Zobel

Senior Director, Personalized Supply Chain

World Courier

Andreas Eggert

Partner, Health & Life Sciences

Oliver Wyman

Anthony Colenburg

Director of Quality

Adicet Bio

Bob Amareld

Head of Supply Chain

Precision Biosciences

Christian Fuchs

Head of Orchestration & Exceptions Management, Cell & Gene Therapy

Roche/ Genentech

Christopher Wiwi

Vice President, Technical Operations

Mnemo Therapeutics

David Kim

Head of Supply Chain

Arcellx

Ed Armstrong

Senior Director, Quality

Mustang Bio

Joy Aho

Director, Product Management

BeTheMatch

Judith Koliwer

Principal Consultant Cell & Gene Therapy

Körber Pharma Software

Justin Dunlevy

Clinical Supply Chain Manager

Precision Biosciences

Kent Thorup

Regional Vice President

QuickSTAT Global Life Science Logistics

Mark Sawicki

President & Chief Executive Officer

Cryoport

Melissa Sebok

Executive Director – Product, Client & Business Development, Direct Patient Care & Emerging Offerings

American Red Cross Biomedical Services

Michael Mehler

Director, Global Site Operations

Immatics

Michelle Andraza

Senior Director, Global Quality Assurance

Exuma Biotech

Ryan Phillips

Strategic Sourcing Manager

Precision Biosciences

Susan Li

Director of Customer Solutions, BioServices & Speciality Logistics

Thermo Fisher Scientific

Tracy Turner

Scientist, Formulation and Cryobiology, Cell Therapy Development Organization

Bristol Myers Squibb

Market Access Track Speakers

Brent Rice

Senior Vice President, Chief Commercial Officer

Autolus

Candice Lo

Global Value & Access Lead, Cell Therapies

Takeda Oncology

Jennifer Chow

Chief Executive Officer, Managing Director

Chimeric Therapeutics

Jodie Wehling

Vice President, Market Access, Payer Marketing & Strategic Accounts

Atara Biotherapeutics

Laura Okpala

Senior Director, Reimbursement Policy

Gilead Sciences

Lynelle Hoch

Senior Vice President

Bristol Myers Squibb

Maria Whitman

Global Head of Pharmaceuticals & Biotechnology

ZS

Mark Trusheim

Strategic Director

NEWDIGS

Michael DeRidder

Senior Vice President Corporate Strategy & New Product Planning

Catamaran Bio

Sankalp Sethi

Principal – Cell & Gene Therapy

ZS

Shirley Bartido

Director, Global Regulatory Affairs Cell Therapy Oncology

Takeda Pharmaceutical Company

Tom Whitehead

Co-founder

Emily Whitehead Foundation